Vivekanandhan Aravindhan

Summary

Publications

  1. ncbi Decreased prevalence of lymphatic filariasis among subjects with type-1 diabetes
    Vivekanandhan Aravindhan
    Laboratory of Molecular Immunology, Anna University K B Chandrashekar Research Centre, Chennai, India
    Am J Trop Med Hyg 83:1336-9. 2010
  2. ncbi Increased levels of both Th1 and Th2 cytokines in subjects with metabolic syndrome (CURES-103)
    Jayagopi Surendar
    Madras Diabetes Research Foundation, Chennai, India
    Diabetes Technol Ther 13:477-82. 2011
  3. ncbi Increased Levels of Serum Granulocyte-Macrophage Colony-Stimulating Factor Is Associated with Activated Peripheral Dendritic Cells in Type 2 Diabetes Subjects (CURES-99)
    Jayagopi Surendar
    1 Madras Diabetes Research Foundation and Dr Mohan s Diabetes Specialties Centre, WHO Collaborating Centre for Non communicable Diseases Prevention and Control, International Diabetes Federation Centre for Education, Chennai, India
    Diabetes Technol Ther 14:344-9. 2012
  4. ncbi Decreased prevalence of lymphatic filariasis among diabetic subjects associated with a diminished pro-inflammatory cytokine response (CURES 83)
    Vivekanandhan Aravindhan
    Madras Diabetes Research Foundation, Chennai, India
    PLoS Negl Trop Dis 4:e707. 2010

Collaborators

Detail Information

Publications4

  1. ncbi Decreased prevalence of lymphatic filariasis among subjects with type-1 diabetes
    Vivekanandhan Aravindhan
    Laboratory of Molecular Immunology, Anna University K B Chandrashekar Research Centre, Chennai, India
    Am J Trop Med Hyg 83:1336-9. 2010
    ..001). Thus, there appears to be a striking inverse relationship between the prevalence of LF and T1DM in southern India...
  2. ncbi Increased levels of both Th1 and Th2 cytokines in subjects with metabolic syndrome (CURES-103)
    Jayagopi Surendar
    Madras Diabetes Research Foundation, Chennai, India
    Diabetes Technol Ther 13:477-82. 2011
    ..The aim of the study was to look at the T-helper (Th) 1 (interleukin [IL]-12, IL-2, and interferon-? [IFN-?]) and Th2 (IL-4, IL-5, and IL-13) cytokines in MS in the high-risk Asian Indian population...
  3. ncbi Increased Levels of Serum Granulocyte-Macrophage Colony-Stimulating Factor Is Associated with Activated Peripheral Dendritic Cells in Type 2 Diabetes Subjects (CURES-99)
    Jayagopi Surendar
    1 Madras Diabetes Research Foundation and Dr Mohan s Diabetes Specialties Centre, WHO Collaborating Centre for Non communicable Diseases Prevention and Control, International Diabetes Federation Centre for Education, Chennai, India
    Diabetes Technol Ther 14:344-9. 2012
    ..Conclusion: The activated state of mDCs and pDCs seen among diabetes subjects might be due to the increased levels of GM-CSF and other pro-inflammatory cytokines...
  4. ncbi Decreased prevalence of lymphatic filariasis among diabetic subjects associated with a diminished pro-inflammatory cytokine response (CURES 83)
    Vivekanandhan Aravindhan
    Madras Diabetes Research Foundation, Chennai, India
    PLoS Negl Trop Dis 4:e707. 2010
    ....